Podcast | Covid-19: USFDA approves remdesivir

BL Internet Desk | Updated on October 23, 2020 Published on October 23, 2020

The US Food and Drug Administration has approved Gilead Sciences’ anti-viral remdesivir, making it the first treatment for Covid-19 to get the final go-ahead from the regulator. Veklury was approved for use in adult and pediatric patients aged 12 and higher, says USFDA.

Listen to the podcast.

Click here for more details.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on October 23, 2020